Skip to main content
. 2020 May 5;8(2):209. doi: 10.3390/vaccines8020209

Figure 7.

Figure 7

Antibody-mediated cross-protection in Rag-/- mice. (a) Timeline of infections, viremia determinations and injection of convalescent CHIKV mouse serum in Rag1-/- mice; (b) Viremias for the indicated alphaviruses before and after injection of anti-CHIKV convalescent serum (n = 4 mice per group). (Limit of detection for each mouse 2 log10CCID50/mL.) For all reductions to undetectable viremia levels for each day relative to day 10, p = 0.037 by Kolmogorov–Smirnov tests (as differences in variance were infinite).